FDA 483 - Duckworth & Kent, Ltd. - May 17, 2018

An FDA inspection of Buckworth & Kent, Ltd., a medical device manufacturer, identified four significant observations related to their quality system. Deficiencies included inadequate medical device reporting procedures, insufficient process validation, poorly documented corrective and preventive actions, and a lack of established environmental control procedures. These issues indicate a need for comprehensive improvements in their quality management system.